about
Beneficial effects of estrogen in a mouse model of cerebrovascular insufficiencyFunctional characterization of rat plasma membrane monoamine transporter in the blood-brain and blood-cerebrospinal fluid barriersFunctional expression of rat ABCG2 on the luminal side of brain capillaries and its enhancement by astrocyte-derived soluble factor(s)Coordinating Etk/Bmx activation and VEGF upregulation to promote cell survival and proliferationQuantitative Targeted Absolute Proteomics for 28 Transporters in Brush-Border and Basolateral Membrane Fractions of Rat KidneyConditionally immortalized retinal capillary endothelial cell lines (TR-iBRB) expressing differentiated endothelial cell functions derived from a transgenic rat.Conditionally immortalized cell lines as a new in vitro model for the study of barrier functions.Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.Brain-to-blood transporters for endogenous substrates and xenobiotics at the blood-brain barrier: an overview of biology and methodology.Targeting choroid plexus epithelia and ventricular ependyma for drug delivery to the central nervous system.Epidermal growth factor targeting of bacteriophage to the choroid plexus for gene delivery to the central nervous system via cerebrospinal fluid.Perspectives on a pharmacokinetics legend: C versus T (contributions over time).Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor.Correlation of induction of ATP binding cassette transporter A5 (ABCA5) and ABCB1 mRNAs with differentiation state of human colon tumor.1α,25-Dihydroxyvitamin D3 enhances cerebral clearance of human amyloid-β peptide(1-40) from mouse brain across the blood-brain barrier.New approaches to in vitro models of blood-brain barrier drug transport.Validation of a P-Glycoprotein (P-gp) Humanized Mouse Model by Integrating Selective Absolute Quantification of Human MDR1, Mouse Mdr1a and Mdr1b Protein Expressions with In Vivo Functional Analysis for Blood-Brain Barrier Transport.A new in vitro model for blood-cerebrospinal fluid barrier transport studies: an immortalized choroid plexus epithelial cell line derived from the tsA58 SV40 large T-antigen gene transgenic rat.Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based ProteomicsScrambled Internal Standard Method for High-Throughput Protein Quantification by Matrix-Assisted Laser Desorption Ionization Tandem Mass Spectrometry.Professor Yuichi Sugiyama: A Brilliant, Creative, Amicable, Charming, and Humorous Pharmaceutical Scientist.Blood-brain barrier transport of ebiratide and its uptake by cerebral neuronal cells.Investigation of the role of breast cancer resistance protein (Bcrp/Abcg2) on pharmacokinetics and central nervous system penetration of abacavir and zidovudine in the mouse.Depletion of vitamin E increases amyloid beta accumulation by decreasing its clearances from brain and blood in a mouse model of Alzheimer disease.Quantitative targeted absolute proteomics-based ADME research as a new path to drug discovery and development: methodology, advantages, strategy, and prospects.Quantitative targeted proteomics for understanding the blood-brain barrier: towards pharmacoproteomics.Pharmacological significance of prostaglandin E2 and D2 transport at the brain barriers.Quantitative Targeted Absolute Proteomics (QTAP)-based Pharmacoproteomics: The Importance of International Collaboration.All-trans retinoic acid enhances gemcitabine cytotoxicity in human pancreatic cancer cell line AsPC-1 by up-regulating protein expression of deoxycytidine kinase.LC-MS/MS Based Quantitation of ABC and SLC Transporter Proteins in Plasma Membranes of Cultured Primary Human Retinal Pigment Epithelium Cells and Immortalized ARPE19 Cell Line.Actin filament-associated protein 1 (AFAP-1) is a key mediator in inflammatory signaling-induced rapid attenuation of intrinsic P-gp function in human brain capillary endothelial cells.The blood-brain barrier fatty acid transport protein 1 (FATP1/SLC27A1) supplies docosahexaenoic acid to the brain, and insulin facilitates transport.Current Progress Toward a Better Understanding of Drug Disposition Within the Lungs: Summary Proceedings of the First Workshop on Drug Transporters in the Lungs.Major involvement of Na(+) -dependent multivitamin transporter (SLC5A6/SMVT) in uptake of biotin and pantothenic acid by human brain capillary endothelial cells.Drug Transporter Protein Quantification of Immortalized Human Lung Cell Lines Derived from Tracheobronchial Epithelial Cells (Calu-3 and BEAS2-B), Bronchiolar-Alveolar Cells (NCI-H292 and NCI-H441), and Alveolar Type II-like Cells (A549) by Liquid CContribution of pannexin 1 and connexin 43 hemichannels to extracellular calcium-dependent transport dynamics in human blood-brain barrier endothelial cells.Critical role of TXNIP in oxidative stress, DNA damage and retinal pericyte apoptosis under high glucose: implications for diabetic retinopathyBlood-to-brain influx transport of nicotine at the rat blood-brain barrier: involvement of a pyrilamine-sensitive organic cation transport process.Identification of transporters associated with Etoposide sensitivity of stomach cancer cell lines and methotrexate sensitivity of breast cancer cell lines by quantitative targeted absolute proteomics.Trans-chromosomic mice containing a human CYP3A cluster for prediction of xenobiotic metabolism in humans.
P50
Q27349876-3778CD15-87B9-408F-9763-428C51E2C27EQ28565238-D1FA0283-83FA-4F6A-947E-E9097572DF10Q28569107-5D6A9818-3016-4E4D-8BB5-5650E464450BQ28579494-80A6D08D-D4A3-436B-98FD-CEEA03FF896BQ28583547-E87ED5EE-FF2F-4B5B-A267-C228D9C58BD3Q31849254-2A2EDEC1-426D-4811-8A54-B9184D56F9F3Q32055768-288E1FCD-13BF-41E7-A968-D5F47EFD5A58Q33303988-D5835FCB-F12F-4C16-B84C-E1F1910F599FQ33569302-EB14F1EE-C86A-497E-A0E7-7D494B21719DQ33788462-EC43CF13-9C3A-4982-853E-2EABE328F803Q34203693-0C675019-BE01-4EB2-AB51-C64BAD697596Q34349207-5B91F269-2E31-4CFB-8693-6CBA63726EA1Q34423801-3D0AFF82-C6C7-4C05-861B-A7F4325B5FA3Q34633290-B1B2E232-007A-46C5-813B-4920A49F9A45Q35183393-8537B973-27C1-4E0C-A1ED-1877D846D59BQ35557433-C0BF2FF0-D3D1-4CD2-8BF4-BDE53CF66447Q35560848-E0D17429-6E72-497D-95FA-B41FC5338D71Q35894214-19B9E66A-8A0E-4ABF-81EE-B895DB3B975CQ36118351-64CF8814-5AA8-467A-B371-B55769D30F27Q36314149-753096B7-88C4-457D-9A9B-A67ECB545090Q36365166-6EEA3862-EEAA-417E-AC89-45AC4F6BAAF4Q36771474-70A41871-E13E-476D-BAE5-525407F955FEQ37387665-9772D77A-C8B2-433E-9F52-298B92BB2CB3Q37446178-3B923D2C-BE92-4CD8-878D-0BB138BFBF15Q37874209-4CB7852E-CC61-4F7C-9AE3-A2B3216893F0Q38202164-2A8901BE-139F-4C0C-A624-0421E1DAD173Q38259310-787168B1-2DCA-4708-8614-9C0B5A825837Q38701683-ED589A32-6475-42D6-9CCB-B94644FBB04AQ38715777-C4E250F3-8CDD-4687-96A3-E41640AC3A29Q38719977-75DFE12D-F606-461A-B4A3-C3C63E835114Q38719997-2C96C57D-2BF6-4FBA-BBD4-48DF66C20842Q38723657-38C36AC0-A13E-4B51-823F-EA510AEA2B18Q38833698-506DBD3F-5203-45BF-B164-C34446B1C143Q38895031-B1BB9686-8CC9-4EB5-8C28-7B13F1017BF1Q38908602-D4CD0674-2EF7-4972-A125-A8F15D21A2E0Q38910876-C8608EB1-8381-4FED-BCCD-D3D76F19B69EQ39203995-66A15D13-2AD3-4F69-9751-532A35C3FB9CQ39228755-8731F7A1-9178-4BCB-A79E-CA754C46C6CCQ39235477-37024336-77DC-46C2-A614-B8ABDEAD0CBAQ39249570-8AE71D69-E86D-4E95-A0C9-2D15D2AF8E6B
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Tetsuya Terasaki
@ast
Tetsuya Terasaki
@en
Tetsuya Terasaki
@es
Tetsuya Terasaki
@nl
Tetsuya Terasaki
@sl
type
label
Tetsuya Terasaki
@ast
Tetsuya Terasaki
@en
Tetsuya Terasaki
@es
Tetsuya Terasaki
@nl
Tetsuya Terasaki
@sl
prefLabel
Tetsuya Terasaki
@ast
Tetsuya Terasaki
@en
Tetsuya Terasaki
@es
Tetsuya Terasaki
@nl
Tetsuya Terasaki
@sl
P108
P106
P1153
7102734642
P21
P31
P496
0000-0002-6332-7575
P569
2000-01-01T00:00:00Z